{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2013 sorted by posted_date descending", "rows": [["FDA-1979-N-0409-0020", "FDA", "FDA-1979-N-0409", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-09T14:38:20Z", null, 0, 0, "090000648055637d"], ["FDA-1979-N-0409-0021", "FDA", "FDA-1979-N-0409", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2014-05-09T14:38:40Z", null, 0, 0, "090000648055637e"], ["FDA-2013-N-1317-0092", "FDA", "FDA-2013-N-1317", "Tentative Determination Regarding Partially Hydrogenated Oils; Request\nfor Comments and for Scientific Data and Information; Extension of\nComment Period", "Notice", "Extension of Comment Period", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", "2014-03-09T04:59:59Z", "2015-06-20T01:30:52Z", "2013-31294", 0, 0, "09000064814e42b9"], ["FDA-2013-N-1634-0001", "FDA", "FDA-2013-N-1634", "Request for Notification From Industry Organizations Interested in\nParticipating in Selection Process for a Nonvoting Industry Representative on the Food Advisory Committee and\nRequest for Nominations for a Nonvoting Industry Representative on\nthe Food Advisory Committee", "Notice", "General Notice", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2014-01-02T14:51:51Z", "2013-31321", 0, 0, "09000064814e428c"], ["FDA-2013-N-0001-0120", "FDA", "FDA-2013-N-0001", "Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2014-01-02T15:01:22Z", "2013-31320", 0, 0, "09000064814e431a"], ["FDA-1980-N-0149-0002", "FDA", "FDA-1980-N-0149", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-08T12:59:27Z", null, 0, 0, "09000064805bcf63"], ["FDA-1979-N-0309-0003", "FDA", "FDA-1979-N-0309", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-12T14:04:10Z", null, 0, 0, "09000064805551a5"], ["FDA-1980-N-0149-0003", "FDA", "FDA-1980-N-0149", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-08T13:00:01Z", null, 0, 0, "09000064805bcf64"], ["FDA-2013-N-1676-0001", "FDA", "FDA-2013-N-1676", "International Drug Scheduling; Convention on Psychotropic\nSubstances; Single Convention on Narcotic Drugs; Tapentadol; Tramadol;\nKetamine; gamma-Butyrolactone; 22 Additional Substances; Request for\nComments", "Notice", "Request for Comments", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "2014-01-30T04:59:59Z", "2024-11-07T23:00:25Z", "2013-31212", 1, 0, "09000064814e192b"], ["FDA-1979-N-0084-0002", "FDA", "FDA-1979-N-0084", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-12T18:35:27Z", null, 0, 0, "0900006480553e83"], ["FDA-2013-N-1155-0002", "FDA", "FDA-2013-N-1155", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Food Labeling\nRegulations", "Notice", "General Notice", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "2014-01-30T04:59:59Z", "2014-01-25T02:04:00Z", "2013-31215", 0, 0, "09000064814e19fd"], ["FDA-2013-N-0001-0119", "FDA", "FDA-2013-N-0001", "Strategies To Address Hemolytic Complications of Immune Globulin\nInfusions; Public Workshop", "Notice", "Public Meetings", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T14:17:54Z", "2013-31213", 0, 0, "09000064814e18f0"], ["FDA-1979-N-0307-0003", "FDA", "FDA-1979-N-0307", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Withdrawal of Proposed Rule", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T18:42:25Z", null, 0, 0, "0900006480555185"], ["FDA-1979-N-0307-0002", "FDA", "FDA-1979-N-0307", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2013-12-30T18:42:24Z", null, 0, 0, "0900006480555184"], ["FDA-1979-N-0084-0003", "FDA", "FDA-1979-N-0084", "Food Labeling; Net Weight Labeling Requirements - Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-12T18:35:45Z", null, 0, 0, "0900006480553e84"], ["FDA-1979-N-0309-0002", "FDA", "FDA-1979-N-0309", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-12T14:03:52Z", null, 0, 0, "09000064805551a4"], ["FDA-1977-N-0005-0357", "FDA", "FDA-1977-N-0005", "Definitions and General Considerations; Revised Procedures re Medicated Feed Applications - Notice of Extension of Comment Period", "Notice", "Notice of Extension", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "1981-07-09T03:59:59Z", "2013-12-27T14:11:12Z", null, 0, 0, "09000064805d7b84"], ["FDA-2013-N-1147-0002", "FDA", "FDA-2013-N-1147", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Preparing a Claim\nof Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition", "Notice", "General Notice", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-01-28T04:59:59Z", "2013-12-27T15:48:56Z", "2013-30998", 0, 0, "09000064814de952"], ["FDA-2011-N-0179-0019", "FDA", "FDA-2011-N-0179", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002", "Notice", "General Notice", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-01-28T04:59:59Z", "2014-04-04T17:00:53Z", "2013-30996", 0, 0, "09000064814deaed"], ["FDA-2013-N-1558-0001", "FDA", "FDA-2013-N-1558", "Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products", "Notice", "60 Day Proposed Information Collection", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-02-26T04:59:59Z", "2015-02-14T00:29:34Z", "2013-30880", 0, 0, "09000064814debdd"], ["FDA-2013-N-1620-0001", "FDA", "FDA-2013-N-1620", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Information From United States Firms and Processors\nThat Export to the European Community", "Notice", "General Notice", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-02-25T04:59:59Z", "2024-11-07T23:00:22Z", "2013-30804", 1, 0, "09000064814dcb64"], ["FDA-2013-N-0001-0118", "FDA", "FDA-2013-N-0001", "Allergenic Products Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T14:51:40Z", "2013-30799", 0, 0, "09000064814dc88e"], ["FDA-2013-N-1618-0001", "FDA", "FDA-2013-N-1618", "Draft Prescription Drug User Fee Act V Information Technology Plan;\nAvailability for Comment", "Notice", "General Notice", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-02-25T04:59:59Z", "2024-11-07T23:00:00Z", "2013-30818", 1, 0, "09000064814dc9f4"], ["FDA-2013-D-1566-0001", "FDA", "FDA-2013-D-1566", "Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances; Availability", "Notice", "Notice of Availability", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-03-27T03:59:59Z", "2014-03-27T01:02:38Z", "2013-30800", 0, 0, "09000064814dcb61"], ["FDA-2013-N-1615-0001", "FDA", "FDA-2013-N-1615", "Draft Generic Drug User Fee Act Information Technology Plan;\nAvailability for Comment", "Notice", "General Notice", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-02-25T04:59:59Z", "2014-02-25T02:03:09Z", "2013-31008", 0, 0, "09000064814dcba6"], ["FDA-2013-N-0001-0117", "FDA", "FDA-2013-N-0001", "Science Advisory Board to the National Center for Toxicological\nResearch; Notice of Meeting", "Notice", "Meeting", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T14:55:25Z", "2013-30578", 0, 0, "09000064814d558a"], ["FDA-2013-N-1496-0001", "FDA", "FDA-2013-N-1496", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Food and Drug Administration Rapid Response\nSurveys (Generic Clearance)", "Notice", "General Notice", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", "2014-02-25T04:59:59Z", "2013-12-24T15:06:13Z", "2013-30630", 0, 0, "09000064814d55d8"], ["FDA-2013-N-0001-0115", "FDA", "FDA-2013-N-0001", "Ophthalmic Devices Panel of the Medical Devices Advisory Committee;\nNotice of Meeting", "Notice", "Meeting", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T14:49:23Z", "2013-30579", 0, 0, "09000064814d52cb"], ["FDA-2013-N-0001-0116", "FDA", "FDA-2013-N-0001", "Orthopaedic and Rehabilitation Devices Panel of the Medical Devices\nAdvisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T14:52:21Z", "2013-30580", 0, 0, "09000064814d531a"], ["FDA-1997-N-0057-0009", "FDA", "FDA-1997-N-0057", "See FDA-1997-N-0057-0008", "Notice", "Correction", "2013-12-23T05:00:00Z", 2013, 12, "2013-12-23T05:00:00Z", null, "2013-12-24T02:03:01Z", null, 0, 0, "09000064814d1f30"], ["FDA-2013-N-0001-0114", "FDA", "FDA-2013-N-0001", "Food and Drug Administration/American Academy of Ophthalmology\nWorkshop on Developing Novel Endpoints for Premium Intraocular\nLenses; Public Workshop", "Notice", "Meeting", "2013-12-19T05:00:00Z", 2013, 12, null, null, "2013-12-19T18:54:11Z", "2013-30148", 0, 0, "09000064814cb583"], ["FDA-2013-N-0796-0002", "FDA", "FDA-2013-N-0796", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Testing\nCommunications on Medical Devices and Radiation-Emitting Products", "Notice", "30 Day Proposed Information Collection", "2013-12-19T05:00:00Z", 2013, 12, "2013-12-19T05:00:00Z", null, "2016-10-28T12:27:02Z", "2013-30149", 0, 0, "09000064814cb0ec"], ["FDA-2013-D-0636-0024", "FDA", "FDA-2013-D-0636", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Unique Device Identification System", "Notice", null, "2013-12-19T05:00:00Z", 2013, 12, null, null, "2013-12-19T18:18:35Z", "2013-30147", 0, 0, "09000064814cb540"], ["FDA-2013-N-1588-0001", "FDA", "FDA-2013-N-1588", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Tobacco Products, Exemptions From Substantial\nEquivalence Requirements", "Notice", "60 Day Proposed Information Collection", "2013-12-19T05:00:00Z", 2013, 12, "2013-12-19T05:00:00Z", "2014-02-19T04:59:59Z", "2022-07-25T17:27:30Z", "2013-30137", 0, 0, "09000064814cb538"], ["FDA-2008-D-0150-0019", "FDA", "FDA-2008-D-0150", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approval; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims", "Notice", "Notice of Approval", "2013-12-19T05:00:00Z", 2013, 12, "2013-12-19T05:00:00Z", null, "2013-12-19T17:20:33Z", "2013-30146", 0, 0, "09000064814cb007"], ["FDA-2013-N-1619-0001", "FDA", "FDA-2013-N-1619", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary\nSupplements", "Notice", "60 Day Proposed Information Collection", "2013-12-19T05:00:00Z", 2013, 12, "2013-12-19T05:00:00Z", "2014-02-19T04:59:59Z", "2024-11-07T23:01:20Z", "2013-30185", 1, 0, "09000064814cb57f"], ["FDA-2013-N-1204-0006", "FDA", "FDA-2013-N-1204", "Draft Risk Profile on Pathogens and Filth in Spices: Availability; Extension of Comment Period", "Notice", "Extension of Comment Period", "2013-12-18T05:00:00Z", 2013, 12, "2013-12-18T05:00:00Z", "2014-03-04T04:59:59Z", "2014-03-07T02:03:54Z", "2013-30055", 0, 0, "09000064814c936a"], ["FDA-2010-N-0308-0045", "FDA", "FDA-2010-N-0308", "See FDA-2010-N-0308-0046", "Notice", "General Notice", "2013-12-18T05:00:00Z", 2013, 12, "2013-12-18T05:00:00Z", "2014-03-04T04:59:59Z", "2014-03-09T03:44:59Z", "2013-30055", 0, 0, "09000064814c8a96"], ["FDA-2010-N-0308-0046", "FDA", "FDA-2010-N-0308", "Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program", "Notice", "General Notice", "2013-12-18T05:00:00Z", 2013, 12, "2013-12-18T05:00:00Z", "2014-03-04T04:59:59Z", "2014-03-06T21:48:24Z", "2013-29822", 0, 0, "09000064814c8999"], ["FDA-2013-N-0001-0113", "FDA", "FDA-2013-N-0001", "Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-17T05:00:00Z", 2013, 12, "2013-12-17T05:00:00Z", null, "2013-12-17T14:24:41Z", "2013-29917", 0, 0, "09000064814c48d2"], ["FDA-2013-N-0001-0112", "FDA", "FDA-2013-N-0001", "Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-17T05:00:00Z", 2013, 12, "2013-12-17T05:00:00Z", null, "2013-12-17T14:21:02Z", "2013-29933", 0, 0, "09000064814c4854"], ["FDA-2013-N-0001-0111", "FDA", "FDA-2013-N-0001", "Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting", "Notice", "General Notice", "2013-12-17T05:00:00Z", 2013, 12, "2013-12-17T05:00:00Z", null, "2013-12-17T14:17:28Z", "2013-29945", 0, 0, "09000064814c478b"], ["FDA-2013-D-0117-0005", "FDA", "FDA-2013-D-0117", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Providing Information About Pediatric Uses of Medical Devices Under Section 515A of the Federal Food, Drug, and Cosmetic Act", "Notice", "General Notice", "2013-12-16T05:00:00Z", 2013, 12, "2013-12-16T05:00:00Z", "2014-01-16T04:59:59Z", "2013-12-16T15:33:09Z", "2013-29796", 0, 0, "09000064814c1d1f"], ["FDA-2011-D-0889-0156", "FDA", "FDA-2011-D-0889", "Guidance for Industry on New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions With Guidance for Industry #209; Availability", "Notice", "Notice of Availability", "2013-12-12T05:00:00Z", 2013, 12, "2013-12-12T05:00:00Z", null, "2013-12-12T16:37:47Z", "2013-29697", 0, 0, "09000064814b9f8c"], ["FDA-2013-N-1504-0001", "FDA", "FDA-2013-N-1504", "Independent Assessment of the Process for the Review of Device Submissions; High Priority Recommendations", "Notice", "General Notice", "2013-12-12T05:00:00Z", 2013, 12, "2013-12-12T05:00:00Z", null, "2013-12-12T15:04:28Z", "2013-29612", 0, 0, "09000064814ba585"], ["FDA-2013-D-0928-0003", "FDA", "FDA-2013-D-0928", "Draft Guidance for Industry on Recommendations for Preparation and Submission of Animal Food Additive Petitions; Reopening of the Comment Period", "Notice", "Notice of Availability", "2013-12-10T05:00:00Z", 2013, 12, "2013-12-10T05:00:00Z", "2014-01-10T04:59:59Z", "2014-01-10T02:01:50Z", "2013-29392", 0, 0, "09000064814b5b83"], ["FDA-2013-D-1478-0001", "FDA", "FDA-2013-D-1478", "Agency Information Collection Activities; Proposed Collection; Comment Request; Providing Waiver-Related Materials in Accordance With Draft Guidance for Industry on Providing Postmarket Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format", "Notice", "60 Day Proposed Information Collection", "2013-12-10T05:00:00Z", 2013, 12, "2013-12-10T05:00:00Z", "2014-02-11T04:59:59Z", "2013-12-10T14:19:50Z", "2013-29393", 0, 0, "09000064814b5a80"], ["FDA-2013-N-1434-0001", "FDA", "FDA-2013-N-1434", "Draft Guidance for Industry on Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules; Availability", "Notice", "Notice of Availability", "2013-12-10T05:00:00Z", 2013, 12, "2013-12-10T05:00:00Z", "2014-03-11T03:59:59Z", "2014-04-06T02:24:30Z", "2013-29395", 0, 0, "09000064814b5c63"], ["FDA-2013-N-0853-0002", "FDA", "FDA-2013-N-0853", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical DevicesCurrent Good Manufacturing Practice Quality System Regulation", "Notice", "30 Day Proposed Information Collection", "2013-12-10T05:00:00Z", 2013, 12, "2013-12-10T05:00:00Z", "2014-01-10T04:59:59Z", "2013-12-10T15:23:32Z", "2013-29394", 0, 0, "09000064814b5b4b"], ["FDA-2013-N-0823-0002", "FDA", "FDA-2013-N-0823", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Over-the-Counter Drugs; Labeling Requirements", "Notice", "30 Day Proposed Information Collection", "2013-12-05T05:00:00Z", 2013, 12, "2013-12-05T05:00:00Z", "2014-01-07T04:59:59Z", "2013-12-08T15:37:58Z", "2013-29079", 0, 0, "09000064814a9e18"], ["FDA-2013-D-1464-0001", "FDA", "FDA-2013-D-1464", "Draft Guidance for Industry on Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Availability", "Notice", "Notice of Availability", "2013-12-05T05:00:00Z", 2013, 12, "2013-12-05T05:00:00Z", "2014-03-06T04:59:59Z", "2014-03-06T02:01:21Z", "2013-29081", 0, 0, "09000064814a9ea0"], ["FDA-2007-D-0369-0277", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry; Availability: Bioequivalence Recommendations for Paliperidone Palmitate Extended-Release Injectable Suspension", "Notice", "Notice of Availability", "2013-12-05T05:00:00Z", 2013, 12, "2013-12-05T05:00:00Z", "2014-02-04T04:59:59Z", "2014-02-13T02:02:08Z", "2013-29080", 0, 0, "09000064814a9e1e"], ["FDA-2013-D-1444-0001", "FDA", "FDA-2013-D-1444", "Draft Guidance; Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Withdrawal of Guidances", "Notice", "Notice of Availability", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-02-04T04:59:59Z", "2014-02-05T02:03:21Z", "2013-28963", 0, 0, "09000064814a6225"], ["FDA-2013-N-0579-0002", "FDA", "FDA-2013-N-0579", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing; Forms FDA 3486 and 3486A", "Notice", "30 Day Proposed Information Collection", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-01-04T04:59:59Z", "2013-12-30T02:01:45Z", "2013-28990", 0, 0, "09000064814a61ed"], ["FDA-2013-N-0795-0002", "FDA", "FDA-2013-N-0795", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Third-Party Review Under the Food and Drug Administration Modernization Act", "Notice", "60 Day Proposed Information Collection", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-01-04T04:59:59Z", "2013-12-04T17:27:21Z", "2013-29010", 0, 0, "09000064814a6173"], ["FDA-2013-N-1429-0001", "FDA", "FDA-2013-N-1429", "Draft Guidance for Industry on Registration for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Availability", "Notice", "Notice of Availability", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-02-04T04:59:59Z", "2020-04-23T20:10:32Z", "2013-28962", 0, 0, "09000064814a62d0"], ["FDA-2012-D-1083-0007", "FDA", "FDA-2012-D-1083", "Guidance for Industry and Food and Drug Administration Staff; Civil Money Penalties for Tobacco Retailers: Responses to Frequently Asked Questions; Availability", "Notice", "Notice of Availability", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", null, "2015-03-24T19:07:23Z", "2013-28961", 0, 0, "09000064814a62d1"], ["FDA-2013-N-1428-0001", "FDA", "FDA-2013-N-1428", "Draft Guidance for Industry on Interim Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Availability", "Notice", "Notice of Availability", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-02-04T04:59:59Z", "2019-07-17T12:21:27Z", "2013-28960", 0, 0, "09000064814a6172"], ["FDA-2013-N-0797-0003", "FDA", "FDA-2013-N-0797", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Tissue Intended for Transplantation", "Notice", "30 Day Proposed Information Collection", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-01-04T04:59:59Z", "2014-01-05T02:56:10Z", "2013-28989", 0, 0, "09000064814a6316"], ["FDA-2013-N-0719-0002", "FDA", "FDA-2013-N-0719", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products", "Notice", "30 Day Proposed Information Collection", "2013-12-02T05:00:00Z", 2013, 12, "2013-12-02T05:00:00Z", "2014-01-03T04:59:59Z", "2013-12-03T01:11:39Z", "2013-28735", 0, 0, "09000064814a2106"], ["FDA-2013-N-0748-0002", "FDA", "FDA-2013-N-0748", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Focus Groups About Drug Products as Used by the Food and Drug Administration", "Notice", "30 Day Proposed Information Collection", "2013-12-02T05:00:00Z", 2013, 12, "2013-12-02T05:00:00Z", "2014-01-03T04:59:59Z", "2013-12-03T01:04:57Z", "2013-28736", 0, 0, "09000064814a1fbf"], ["FDA-2013-N-0716-0002", "FDA", "FDA-2013-N-0716", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Designated New Animal Drugs for Minor Use and Minor Species", "Notice", "General Notice", "2013-11-29T05:00:00Z", 2013, 11, "2013-11-29T05:00:00Z", "2013-12-31T04:59:59Z", "2013-11-29T17:13:49Z", "2013-28598", 0, 0, "090000648149f1ca"], ["FDA-2013-N-1439-0001", "FDA", "FDA-2013-N-1439", "Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Event Program for Medical Products", "Notice", "General Notice", "2013-11-29T05:00:00Z", 2013, 11, "2013-11-29T05:00:00Z", "2014-01-29T04:59:59Z", "2013-11-29T17:16:39Z", "2013-28600", 0, 0, "090000648149f214"], ["FDA-2013-N-1422-0001", "FDA", "FDA-2013-N-1422", "Agency Information Collection Activities; Proposed Collection; Comment Request; Eye Tracking Study of Direct-to-Consumer Prescription Drug Advertisement Viewing", "Notice", "General Notice", "2013-11-29T05:00:00Z", 2013, 11, "2013-11-29T05:00:00Z", "2014-01-29T04:59:59Z", "2014-09-04T17:41:07Z", "2013-28599", 0, 0, "090000648149f075"], ["FDA-2012-D-0880-0009", "FDA", "FDA-2012-D-0880", "Draft Guidance for Industry on Generic Drug User Fee Amendments of 2012: Questions and Answers (Revision 1); Reopening of the Comment Period", "Notice", "General Notice", "2013-11-27T05:00:00Z", 2013, 11, "2013-11-27T05:00:00Z", "2013-12-12T04:59:59Z", "2016-11-18T14:46:02Z", "2013-28392", 0, 0, "090000648149c2b6"], ["FDA-2013-N-1424-0001", "FDA", "FDA-2013-N-1424", "Transport Format for the Submission of Regulatory Study Data; Notice of Pilot Project", "Notice", "General Notice", "2013-11-27T05:00:00Z", 2013, 11, "2013-11-27T05:00:00Z", "2014-01-28T04:59:59Z", "2024-11-12T05:23:15Z", "2013-28391", 1, 0, "090000648149c255"], ["FDA-2013-N-0001-0110", "FDA", "FDA-2013-N-0001", "Risk Communications Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-11-27T05:00:00Z", 2013, 11, "2013-11-27T05:00:00Z", null, "2013-11-27T15:57:46Z", "2013-28435", 0, 0, "090000648149c214"], ["FDA-2013-N-1423-0001", "FDA", "FDA-2013-N-1423", "Agency Information Collection Activities; Proposed Collection; Comment Request; Importer's Entry Notice", "Notice", "General Notice", "2013-11-27T05:00:00Z", 2013, 11, "2013-11-27T05:00:00Z", "2014-01-28T04:59:59Z", "2024-11-12T05:23:18Z", "2013-28438", 1, 0, "090000648149c36a"], ["FDA-2007-D-0369-0275", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry on Bioequivalence Recommendations for Fluticasone Propionate; Salmeterol Xinafoate; Reopening of the Comment Period", "Notice", "Notice of Availability", "2013-11-27T05:00:00Z", 2013, 11, "2013-11-27T05:00:00Z", "2013-12-12T04:59:59Z", "2013-12-08T18:23:54Z", "2013-28394", 0, 0, "090000648149c332"], ["FDA-2013-N-0002-0040", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid", "Notice", "General Notice", "2013-11-26T05:00:00Z", 2013, 11, "2013-11-26T05:00:00Z", null, "2013-11-26T14:17:06Z", "2013-28255", 0, 0, "0900006481498795"], ["FDA-2011-D-0305-0058", "FDA", "FDA-2011-D-0305", "Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2013-11-25T05:00:00Z", 2013, 11, "2013-11-25T05:00:00Z", null, "2013-11-26T13:37:08Z", "2013-28084", 0, 0, "0900006481495921"], ["FDA-2012-D-1038-0017", "FDA", "FDA-2012-D-1038", "Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products; Availability", "Notice", "Notice of Availability", "2013-11-25T05:00:00Z", 2013, 11, "2013-11-25T05:00:00Z", null, "2013-11-26T13:43:05Z", "2013-28173", 0, 0, "0900006481495aaa"], ["FDA-2013-N-0002-0038", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone", "Notice", "General Notice", "2013-11-22T05:00:00Z", 2013, 11, "2013-11-22T05:00:00Z", null, "2013-11-22T14:37:17Z", "2013-27916", 0, 0, "09000064814910b5"], ["FDA-2013-D-0269-0003", "FDA", "FDA-2013-D-0269", "Guidance for Industry: Purchasing Reef Fish Species Associated with the Hazard of Ciguatera Fish Poisoning; Availability", "Notice", "Notice of Availability", "2013-11-22T05:00:00Z", 2013, 11, "2013-11-22T05:00:00Z", null, "2013-11-22T15:33:10Z", "2013-27913", 0, 0, "090000648149122c"], ["FDA-2013-P-0573-0003", "FDA", "FDA-2013-P-0573", "Determination That BANZEL (Rufinamide) Tablet, 100 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "General Notice", "2013-11-21T05:00:00Z", 2013, 11, "2013-11-21T05:00:00Z", null, "2013-11-21T14:54:32Z", "2013-27874", 0, 0, "090000648148e297"], ["FDA-2013-N-1432-0001", "FDA", "FDA-2013-N-1432", "Agency Information Collection Activities; Proposed Collection; Comment Request; Guide to Minimize Microbial Food Safety Hazards of Fresh-Cut Fruits and Vegetables", "Notice", "General Notice", "2013-11-20T05:00:00Z", 2013, 11, "2013-11-20T05:00:00Z", "2014-01-22T04:59:59Z", "2014-01-22T02:01:42Z", "2013-27782", 0, 0, "090000648148bb1a"], ["FDA-2013-N-0001-0108", "FDA", "FDA-2013-N-0001", "Changing Regulatory and Reimbursement Paradigms for Medical Devices in the Treatment of Obesity and Metabolic Diseases: How to Estimate and Reward True Patient-Centric Value in Innovation; Public Workshop", "Notice", "Meeting", "2013-11-20T05:00:00Z", 2013, 11, "2013-11-20T05:00:00Z", null, "2013-11-20T15:29:32Z", "2013-27771", 0, 0, "090000648148bb54"], ["FDA-1999-D-4079-0004", "FDA", "FDA-1999-D-4079", "Draft Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability", "Notice", "Notice of Availability", "2013-11-20T05:00:00Z", 2013, 11, "2013-11-20T05:00:00Z", "2014-01-25T04:59:59Z", "2014-01-17T02:02:42Z", "2013-27770", 0, 0, "090000648148bad1"], ["FDA-2013-D-1358-0001", "FDA", "FDA-2013-D-1358", "Draft Guidance for Industry: Recommendations for Premarket Notification (510(k)) Submissions for Nucleic Acid-Based Human Leukocyte Antigen Test Kits Used for Matching of Donors and Recipients in Transfusion and Transplantation; Availability", "Notice", "Notice of Availability", "2013-11-20T05:00:00Z", 2013, 11, "2013-11-20T05:00:00Z", "2014-02-19T04:59:59Z", "2015-07-13T17:54:08Z", "2013-27774", 0, 0, "090000648148bc0a"], ["FDA-2013-D-0576-0003", "FDA", "FDA-2013-D-0576", "Draft Guidance for Industry:  Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products; Extension of Comment Period", "Notice", "Notice of Availability", "2013-11-20T05:00:00Z", 2013, 11, "2013-11-20T05:00:00Z", "2014-05-10T03:59:59Z", "2014-05-13T14:34:04Z", "2013-27769", 0, 0, "090000648148ba3d"], ["FDA-2013-N-0879-0002", "FDA", "FDA-2013-N-0879", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe and Sanitary Processing and Importing of Fish and Fishery Products", "Notice", "30 Day Proposed Information Collection", "2013-11-20T05:00:00Z", 2013, 11, "2013-11-20T05:00:00Z", "2013-12-21T04:59:59Z", "2016-12-08T13:41:55Z", "2013-27775", 0, 0, "090000648148ba3c"], ["FDA-2013-N-1427-0001", "FDA", "FDA-2013-N-1427", "Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice", "Notice", "60 Day Proposed Information Collection", "2013-11-20T05:00:00Z", 2013, 11, "2013-11-20T05:00:00Z", "2014-01-22T04:59:59Z", "2016-08-09T18:09:39Z", "2013-27811", 0, 0, "090000648148bb55"], ["FDA-2013-N-0878-0002", "FDA", "FDA-2013-N-0878", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Notification for a New Dietary Ingredient", "Notice", "General Notice", "2013-11-18T05:00:00Z", 2013, 11, "2013-11-18T05:00:00Z", "2013-12-19T04:59:59Z", "2015-02-11T23:13:29Z", "2013-27536", 0, 0, "0900006481486d8c"], ["FDA-2013-N-1119-0002", "FDA", "FDA-2013-N-1119", "Agency Information Collection Activities; Proposed Collection; Comment Request; Food Canning Establishment Registration, Process Filing, and Recordkeeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically Sealed Containers; Extension of Comment Period", "Notice", "Extension of Comment Period", "2013-11-18T05:00:00Z", 2013, 11, "2013-11-18T05:00:00Z", null, "2024-11-12T05:23:33Z", "2013-27537", 1, 0, "0900006481486d8d"], ["FDA-2013-N-1394-0001", "FDA", "FDA-2013-N-1394", "Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Special Protocol Assessment", "Notice", "General Notice", "2013-11-18T05:00:00Z", 2013, 11, "2013-11-18T05:00:00Z", "2014-01-18T04:59:59Z", "2014-01-14T19:56:34Z", "2013-27503", 0, 0, "0900006481486bba"], ["FDA-2013-D-0715-0001", "FDA", "FDA-2013-D-0715", "Draft Guidance for Industry on Acrylamide in Foods; Availability", "Notice", "Notice of Availability", "2013-11-15T05:00:00Z", 2013, 11, "2013-11-15T05:00:00Z", "2014-01-15T04:59:59Z", "2014-01-15T02:03:26Z", "2013-27362", 0, 0, "0900006481481e8f"], ["FDA-2013-N-1038-0003", "FDA", "FDA-2013-N-1038", "Over-the-Counter Ophthalmic Drug Products--Emergency Use Eyewash Products; Rescheduling of Public Hearing", "Notice", "Public Meetings", "2013-11-15T05:00:00Z", 2013, 11, "2013-11-15T05:00:00Z", "2014-06-07T03:59:59Z", "2014-06-07T01:06:55Z", "2013-27359", 0, 0, "0900006481481db2"], ["FDA-2013-N-1306-0001", "FDA", "FDA-2013-N-1306", "International Medical Device Regulators Forum; Medical Device Single Audit Program International Coalition Pilot Program; Availability", "Notice", "Announcement", "2013-11-15T05:00:00Z", 2013, 11, "2013-11-15T05:00:00Z", null, "2024-11-12T05:24:37Z", "2013-27358", 1, 0, "0900006481481dfb"], ["FDA-1994-D-0007-0003", "FDA", "FDA-1994-D-0007", "Guidance for Industry; Availability: Studies to Evaluate the Utility of Anti-Salmonella Chemical Food Additives in Feeds", "Notice", "Request for Comments", "2013-11-14T05:00:00Z", 2013, 11, "2013-11-14T05:00:00Z", "2014-01-14T04:59:59Z", "2014-01-18T02:04:25Z", "2013-27194", 0, 0, "090000648147d87c"], ["FDA-2013-N-1393-0001", "FDA", "FDA-2013-N-1393", "Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions", "Notice", "60 Day Proposed Information Collection", "2013-11-14T05:00:00Z", 2013, 11, "2013-11-14T05:00:00Z", "2014-01-14T04:59:59Z", "2016-10-24T13:43:28Z", "2013-27226", 0, 0, "090000648147d67b"], ["FDA-2000-N-0110-0008", "FDA", "FDA-2000-N-0110", "Debarment Orders: Bruce I. Diamond; Denial of Hearing", "Notice", "General Notice", "2013-11-14T05:00:00Z", 2013, 11, "2013-11-14T05:00:00Z", null, "2013-11-14T15:45:07Z", "2013-27186", 0, 0, "090000648147d79f"], ["FDA-2013-D-1279-0001", "FDA", "FDA-2013-D-1279", "Medical Device Development Tools; Draft Guidance for Industry, Tool Developers, and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2013-11-14T05:00:00Z", 2013, 11, "2013-11-14T05:00:00Z", null, "2013-11-14T16:39:29Z", "2013-27233", 0, 0, "090000648147d82e"], ["FDA-2013-D-0880-0006", "FDA", "FDA-2013-D-0880", "Draft Guidance for Industry on Frequently Asked Questions About Medical Foods; Second Edition; Reopening of the Comment Period", "Notice", "General Notice", "2013-11-14T05:00:00Z", 2013, 11, "2013-11-14T05:00:00Z", "2013-12-17T04:59:59Z", "2016-03-18T18:15:07Z", "2013-27213", 0, 0, "090000648147d709"], ["FDA-2013-N-1152-0001", "FDA", "FDA-2013-N-1152", "Agency Information Collection Activities; Proposed Collection; Comment Request; Petition to Request an Exemption From 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements", "Notice", "General Notice", "2013-11-14T05:00:00Z", 2013, 11, "2013-11-14T05:00:00Z", "2014-01-14T04:59:59Z", "2014-01-14T16:41:07Z", "2013-27222", 0, 0, "090000648147d67d"], ["FDA-2013-N-0001-0106", "FDA", "FDA-2013-N-0001", "Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-11-12T05:00:00Z", 2013, 11, "2013-11-12T05:00:00Z", null, "2013-11-12T19:54:30Z", "2013-26891", 0, 0, "090000648147745b"], ["FDA-2013-N-0001-0105", "FDA", "FDA-2013-N-0001", "Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-11-12T05:00:00Z", 2013, 11, "2013-11-12T05:00:00Z", null, "2013-11-12T19:51:02Z", "2013-26868", 0, 0, "0900006481477329"], ["FDA-2013-N-1361-0001", "FDA", "FDA-2013-N-1361", "Determination That ADDERALL (Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate) Tablet and 13 Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "General Notice", "2013-11-12T05:00:00Z", 2013, 11, "2013-11-12T05:00:00Z", null, "2013-11-12T19:58:09Z", "2013-26856", 0, 0, "09000064814774f2"], ["FDA-2013-N-0764-0005", "FDA", "FDA-2013-N-0764", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Animal Feed Regulatory Program Standards", "Notice", "30 Day Proposed Information Collection", "2013-11-08T05:00:00Z", 2013, 11, "2013-11-08T05:00:00Z", "2013-12-10T04:59:59Z", "2016-04-04T11:10:30Z", "2013-26778", 0, 0, "090000648147379d"], ["FDA-2013-N-0001-0107", "FDA", "FDA-2013-N-0001", "Sixth Annual Sentinel Initiative; Public Workshop", "Notice", "Meeting", "2013-11-08T05:00:00Z", 2013, 11, "2013-11-08T05:00:00Z", null, "2013-11-12T20:11:03Z", "2013-26855", 0, 0, "09000064814737a3"], ["FDA-2013-N-1317-0001", "FDA", "FDA-2013-N-1317", "Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for Scientific Data and Information", "Notice", "Request for Comments", "2013-11-08T05:00:00Z", 2013, 11, "2013-11-08T05:00:00Z", "2014-01-08T04:59:59Z", "2014-12-14T02:23:47Z", "2013-26854", 0, 0, "090000648147367f"]], "truncated": false, "filtered_table_rows_count": 718, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2013"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013", "results": [{"value": "FDA", "label": "FDA", "count": 718, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2013", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013", "results": [{"value": "Notice", "label": "Notice", "count": 718, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013", "results": [{"value": 2013, "label": 2013, "count": 718, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_facet_date=last_modified"}], "next": "2013-11-08T05~3A00~3A00Z,FDA-2013-N-1317-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2013&_next=2013-11-08T05~3A00~3A00Z%2CFDA-2013-N-1317-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 935.2940910030156, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}